Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

87 ArticlesPharmaceuticals

6 / 9

Will Britain’s exit from Europe impact the Pharmaceutical Industry?

Yes. Remember this that UK on its own, represents 2.5% of the world pharmaceutical market (the market is over $1 trillion) and the market has not grown to this ...
United-Kingdom.png

Sun Pharma Announces Buyback of Equity Shares – 7.5 million shares at Rs. 900 a piece

  Sun Pharmaceutical Industries announced that, the Board of Directors of the Company at its meeting held on June 23, 2016 approved the buyback of its ...
Sun_Pharma_logo.jpg

Unichem Laboratories receives ANDA approval for Donepezil Hydrochloride Tablets

Unichem Laboratories is a specialty pharmaceutical company with a large basket of branded generics in India and several other markets across the world. ...
Unichem-Labs2.png

Biocon receives approval from Drug Controller General of India for the first ever clinical trial of a siRNA therapy

Biocon – one of the largest emerging global biopharmaceutical enterprise (has a rich pipeline of Biosimilars and Novel Biologics at various stages of ...
Biocon_Quark.png

Lupin recalls 54,472 vials of Ceftriaxone, first recall post receipt of EIR from USFDA

Drug major Lupin Pharmaceuticals Inc. (the US subsidiary of Lupin Pharmaceuticals), initiated a recall of Ceftriaxone Sodium (Sterile) vials and the API ...
Lupin-Logo-2.png

Exclusive: Lupin Pharmaceuticals slapped form 483 for Mandideep facility

Welcome to the third and final part of the 3 part exclusive unwrapping of the observations reported from the US FDA’s inspection of Lupin Pharmaceutical’s ...
04-Lupin-fda-3-facilities-Mandideep.png

Exclusive: Lupin Pharmaceuticals slapped form 483 for Goa facility

Welcome to the second of the 3 part exclusive unwrapping of the observations reported from the US FDA’s inspection of Lupin Pharmaceutical’s facilities. If ...
03-Lupin-fda-3-facilities-Goa.png

Exclusive: Lupin Pharmaceuticals slapped form 483 for Aurangabad facility

Welcome to the first of the 3 part exclusive unwrapping of the observations reported from the US FDA’s inspection of Lupin Pharmaceutical’s facilities. If ...
02-Lupin-fda-3-facilities-Aurangabad.png

Exclusive: Lupin Pharmaceuticals slapped form 483 for 3 facilities

Today we at Capital Mind bring you some exclusive articles. This follows our earlier post on Lupin’s Mandideep facility FDA inspection which was brought to ...
01-Lupin-fda-3-facilities.png

Anuh Pharma's Good Manufacturing Practices (GMP) certificate withdrawn

Anuh Pharma Limited (APL) – a BSE only listed stock, is part of Mumbai based SK group of companies is a mid-sized player in the API/bulk drug industry and is ...